Federal Data Hub › HRSA 340B · JSON
OFFICE OF PUBLIC HEALTH · 340B ID RWIID70112
ParticipatingRWIID
STD/HIV Program is a RWIID enrolled in the federal 340B Drug Pricing Program in NEW ORLEANS, LA. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 20 contract-pharmacy arrangement(s) (14 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| AFFORDABLE PHARMACY | BATON ROUGE, LA | 2014-04-01 | 2018-12-31 | 64900 |
| AVITA PHARMACY 1028 | DALLAS, TX | 2013-04-01 | — | 3349 |
| AVITA PHARMACY 1037 | NEW ORLEANS, LA | 2013-04-01 | — | 889 |
| AVITA PHARMACY 1038 | NEW ORLEANS, LA | 2016-07-01 | — | 103990 |
| AVITA PHARMACY 1039 | NEW ORLEANS, LA | 2019-04-01 | — | 119979 |
| AVITA PHARMACY 1040 | BATON ROUGE, LA | 2013-04-01 | — | 1799 |
| BRFHH MONROE LLC | MONROE, LA | 2014-07-24 | — | 91597 |
| BRFHH SHREVEPORT LLC | SHREVEPORT, LA | 2015-01-08 | — | 92519 |
| DOC-YOUR-DOSE PHARMACY | GROSSE TETE, LA | 2014-01-01 | 2017-11-01 | 1268 |
| DOC-YOUR-DOSE PHARMACY | GROSSE TETE, LA | 2018-07-01 | 2024-04-24 | 110302 |
| KINGS PHARMACY | SHREVEPORT, LA | 2015-01-01 | — | 65091 |
| LALLIE KEMP REGIONAL MED CTR | INDEPENDENCE, LA | 2011-04-06 | — | 2183 |
| MIDCITY PHARMACY | BATON ROUGE, LA | 2018-07-01 | — | 114158 |
| MOSS MEMORIAL CLINIC PHARMACY | Lake Charles, LA | 2014-04-01 | — | 88695 |
| O'DONOVAN PHARMACY | BATON ROUGE, LA | 2013-04-14 | 2019-12-31 | 87174 |
| OUR LADY OF THE ANGELS OUTPATIENT PHARMA | BOGALUSA, LA | 2014-07-24 | 2024-04-24 | 92008 |
| PARISH PHARMACY INC | SHREVEPORT, LA | 2022-07-01 | — | 134141 |
| RELIANT MEDICAL LLC DBA RELIANT HEALTHCA | MONROE, LA | 2014-01-01 | — | 1810 |
| UNIVERSITY HOSPITAL & CLINICS, INC. | LAFAYETTE, LA | 2014-04-07 | — | 90646 |
| WINN DIXIE MONTGOMERY, LLC. | BATON ROUGE, LA | 2014-01-01 | 2024-04-24 | 64999 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.